Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases

OBJECTIVEOur objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant metastases (M1). PATIENTS AND METHODSRadioiodine (I) therapy was applied in 77 differentiated thyroid carcinoma patients with M1 (31 patients wit...

Full description

Saved in:
Bibliographic Details
Published in:Nuclear medicine communications Vol. 30; no. 7; pp. 558 - 564
Main Authors: Mihailovic, Jasna M, Stefanovic, Ljubomir J, Malesevic, Milica D, Erak, Marko D, Tesanovic, Dusanka D
Format: Journal Article
Language:English
Published: England Lippincott Williams & Wilkins, Inc 01-07-2009
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract OBJECTIVEOur objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant metastases (M1). PATIENTS AND METHODSRadioiodine (I) therapy was applied in 77 differentiated thyroid carcinoma patients with M1 (31 patients with M1-initial and 46 patients with M1-late). The median follow-up of patients was 72.7 months. Probability of disease-specific survival (DSS) was analyzed by the Kaplan–Meier method and the log rank test, while the significance of differences between groups was calculated by the t-test of proportions. RESULTSFollicular carcinomas were more frequent in patients with M1-late (P<0.05). During the follow-up, 58% of the patients died39% of cases had disease related deaths, while 42% had complete remission of disease. Stable disease and progressive disease were significantly influenced by age only (P = 0.0122), while I uptake, histological type, and sex had no influence (P = 0.1235; P = 0.340; P = 0.8540, respectively). Remission of disease (complete and partial) was not significantly influenced by age, sex, histological type, and I accumulation (P = 0.0644; P = 0.8452; P = 0.6308; P = 0.7675, respectively). DSS in patients with M1-initial and M1-late at 5 years was 71 and 50%, respectively and 62 and 41% at 10 years, respectively, without significant difference (P = 0.2582). Disease related deaths appeared more frequent in patients at 45 years of age or older, significantly caused by distant metastases (P<0.001). CONCLUSIONDistant metastases occur late more often in patients with follicular carcinoma while M1-initial is detected more often in patients with papillary carcinoma. DSS was not significantly different among patients with M1-intial and M1-late. The risk of death from M1 increased after the age of 45 years.
AbstractList OBJECTIVEOur objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant metastases (M1). PATIENTS AND METHODSRadioiodine (I) therapy was applied in 77 differentiated thyroid carcinoma patients with M1 (31 patients with M1-initial and 46 patients with M1-late). The median follow-up of patients was 72.7 months. Probability of disease-specific survival (DSS) was analyzed by the Kaplan–Meier method and the log rank test, while the significance of differences between groups was calculated by the t-test of proportions. RESULTSFollicular carcinomas were more frequent in patients with M1-late (P<0.05). During the follow-up, 58% of the patients died39% of cases had disease related deaths, while 42% had complete remission of disease. Stable disease and progressive disease were significantly influenced by age only (P = 0.0122), while I uptake, histological type, and sex had no influence (P = 0.1235; P = 0.340; P = 0.8540, respectively). Remission of disease (complete and partial) was not significantly influenced by age, sex, histological type, and I accumulation (P = 0.0644; P = 0.8452; P = 0.6308; P = 0.7675, respectively). DSS in patients with M1-initial and M1-late at 5 years was 71 and 50%, respectively and 62 and 41% at 10 years, respectively, without significant difference (P = 0.2582). Disease related deaths appeared more frequent in patients at 45 years of age or older, significantly caused by distant metastases (P<0.001). CONCLUSIONDistant metastases occur late more often in patients with follicular carcinoma while M1-initial is detected more often in patients with papillary carcinoma. DSS was not significantly different among patients with M1-intial and M1-late. The risk of death from M1 increased after the age of 45 years.
OBJECTIVEOur objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant metastases (M1).PATIENTS AND METHODSRadioiodine (131I) therapy was applied in 77 differentiated thyroid carcinoma patients with M1 (31 patients with M1-initial and 46 patients with M1-late). The median follow-up of patients was 72.7 months. Probability of disease-specific survival (DSS) was analyzed by the Kaplan-Meier method and the log rank test, while the significance of differences between groups was calculated by the t-test of proportions.RESULTSFollicular carcinomas were more frequent in patients with M1-late (P<0.05). During the follow-up, 58% of the patients died: 39% of cases had disease related deaths, while 42% had complete remission of disease. Stable disease and progressive disease were significantly influenced by age only (P = 0.0122), while 131I uptake, histological type, and sex had no influence (P = 0.1235; P = 0.340; P = 0.8540, respectively). Remission of disease (complete and partial) was not significantly influenced by age, sex, histological type, and 131I accumulation (P = 0.0644; P = 0.8452; P = 0.6308; P = 0.7675, respectively). DSS in patients with M1-initial and M1-late at 5 years was 71 and 50%, respectively and 62 and 41% at 10 years, respectively, without significant difference (P = 0.2582). Disease related deaths appeared more frequent in patients at 45 years of age or older, significantly caused by distant metastases (P<0.001).CONCLUSIONDistant metastases occur late more often in patients with follicular carcinoma while M1-initial is detected more often in patients with papillary carcinoma. DSS was not significantly different among patients with M1-initial and M1-late. The risk of death from M1 increased after the age of 45 years.
Our objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant metastases (M1). Radioiodine (131I) therapy was applied in 77 differentiated thyroid carcinoma patients with M1 (31 patients with M1-initial and 46 patients with M1-late). The median follow-up of patients was 72.7 months. Probability of disease-specific survival (DSS) was analyzed by the Kaplan-Meier method and the log rank test, while the significance of differences between groups was calculated by the t-test of proportions. Follicular carcinomas were more frequent in patients with M1-late (P<0.05). During the follow-up, 58% of the patients died: 39% of cases had disease related deaths, while 42% had complete remission of disease. Stable disease and progressive disease were significantly influenced by age only (P = 0.0122), while 131I uptake, histological type, and sex had no influence (P = 0.1235; P = 0.340; P = 0.8540, respectively). Remission of disease (complete and partial) was not significantly influenced by age, sex, histological type, and 131I accumulation (P = 0.0644; P = 0.8452; P = 0.6308; P = 0.7675, respectively). DSS in patients with M1-initial and M1-late at 5 years was 71 and 50%, respectively and 62 and 41% at 10 years, respectively, without significant difference (P = 0.2582). Disease related deaths appeared more frequent in patients at 45 years of age or older, significantly caused by distant metastases (P<0.001). Distant metastases occur late more often in patients with follicular carcinoma while M1-initial is detected more often in patients with papillary carcinoma. DSS was not significantly different among patients with M1-initial and M1-late. The risk of death from M1 increased after the age of 45 years.
Author Malesevic, Milica D
Mihailovic, Jasna M
Stefanovic, Ljubomir J
Erak, Marko D
Tesanovic, Dusanka D
AuthorAffiliation Departments of Nuclear Medicine and Radiotherapy, Oncology Institute of Vojvodina, Institutski put, Sremska Kamenica, Serbia
AuthorAffiliation_xml – name: Departments of Nuclear Medicine and Radiotherapy, Oncology Institute of Vojvodina, Institutski put, Sremska Kamenica, Serbia
Author_xml – sequence: 1
  givenname: Jasna
  surname: Mihailovic
  middlename: M
  fullname: Mihailovic, Jasna M
  organization: Departments of Nuclear Medicine and Radiotherapy, Oncology Institute of Vojvodina, Institutski put, Sremska Kamenica, Serbia
– sequence: 2
  givenname: Ljubomir
  surname: Stefanovic
  middlename: J
  fullname: Stefanovic, Ljubomir J
– sequence: 3
  givenname: Milica
  surname: Malesevic
  middlename: D
  fullname: Malesevic, Milica D
– sequence: 4
  givenname: Marko
  surname: Erak
  middlename: D
  fullname: Erak, Marko D
– sequence: 5
  givenname: Dusanka
  surname: Tesanovic
  middlename: D
  fullname: Tesanovic, Dusanka D
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19436230$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1vEzEQhi1URNPCP0DIJ25b7B1nveGGKj4qNXCB82rWniUGrx1sr6L-B340DomE1AMnS6NnnrHe94pdhBiIsZdS3Eix0W-2n7c3YhQSCNoeWmNaHJ-wlVQamnXX9hdsJaSCBjroLtlVzj-EED10-hm7lBsFXQtixX5vqWAuWJzh1k0TJQrFYSHLy-4hRWe5wWRciDO-5ca74Ax6PmPA7zRXlmOwPC7FxJl4nKokE2biLvB9tVYi84MruzpwVez_8r4eOJIFq2A-_SBTfs6eTugzvTi_1-zbh_dfbz81918-3t2-u28MrNXYaA2dWCuppabeEmpQPVmr4BhDr62hngB7i0oh4AYnUkpBq0nULEaScM1en7z7FH8tlMswu2zIewwUlzx01bhRAiqoTqBJMedE07BPbsb0MEgxHFsYagvD4xbq2quzfxlnsv-WzrFXoD8Bh-gLpfzTLwdKw47Ql93_3X8AQPGcOQ
CitedBy_id crossref_primary_10_1016_j_raem_2017_05_001
crossref_primary_10_1097_RLU_0000000000005138
crossref_primary_10_1007_s00268_013_2006_9
crossref_primary_10_1089_thy_2016_0582
crossref_primary_10_1007_s12020_018_1713_2
crossref_primary_10_1016_j_bcp_2011_08_021
crossref_primary_10_1308_rcsann_2016_0300
crossref_primary_10_4103_ijem_ijem_455_21
crossref_primary_10_1089_thy_2011_0535
crossref_primary_10_1634_theoncologist_2009_0190
crossref_primary_10_1007_s00259_016_3485_3
crossref_primary_10_1007_s00405_017_4532_9
crossref_primary_10_1007_s12020_019_01991_0
crossref_primary_10_1007_s12149_011_0559_y
crossref_primary_10_1007_s00268_013_2213_4
Cites_doi 10.1046/j.1365-2265.2002.01482.x
10.1016/j.surg.2007.06.011
10.1111/j.1365-2265.2005.02358.x
10.1002/1097-0142(19840215)53:4<982::AID-CNCR2820530427>3.0.CO;2-E
10.1067/msy.2000.109728
10.1016/0046-8177(90)90228-W
10.1053/jpsu.2000.6935
10.1002/1097-0142(19881001)62:7<1381::AID-CNCR2820620724>3.0.CO;2-R
10.1677/ERC-07-0229
10.1111/j.1365-2265.2005.02304.x
10.1089/thy.1999.9.1227
10.1016/S1072-7515(03)00332-6
10.1210/jcem-63-4-960
10.1210/jc.2005-2838
10.1055/s-0037-1620881
10.1002/cncr.22956
10.1210/jcem-56-6-1131
10.1097/00000478-200208000-00005
10.1259/0007-1285-57-676-323
10.1016/S0002-9610(97)00158-X
10.1210/jcem-67-3-501
ContentType Journal Article
Copyright 2009 Lippincott Williams & Wilkins, Inc.
Copyright_xml – notice: 2009 Lippincott Williams & Wilkins, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1097/MNM.0b013e32832cc2ab
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1473-5628
EndPage 564
ExternalDocumentID 10_1097_MNM_0b013e32832cc2ab
19436230
10.1097/MNM.0b013e32832cc2ab
Genre Journal Article
GroupedDBID -
.Z2
0R
123
4Q1
4Q2
4Q3
53G
5VS
71W
8L-
8WZ
A6W
AAPBV
AARTV
AAYEP
ABBUW
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACWDW
ACWRI
ACXNZ
ADFPA
ADNKB
AE3
AENEX
AFUWQ
AHULI
AHVBC
AJIOK
AJNYG
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
AWKKM
BQLVK
C45
CAG
COF
CS3
DU5
DUNZO
E.X
EBS
EJD
EX3
F2K
F2L
F5P
FL-
H0
H0~
HZ
IN
IN~
JF9
JG8
JK3
JK8
K8S
KD2
KMI
L-C
N9A
N~M
O9-
OAG
OAH
OCUKA
ODA
OHASI
OL1
OLG
OLV
OLW
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OWW
OWY
OXXIT
P-K
P2P
R58
RIG
RLZ
RSW
S4R
S4S
V2I
WOQ
WOW
X3V
X3W
Z2
ZA5
ZGI
---
.-D
0R~
AAAAV
AAHPQ
AAIQE
AASCR
ABASU
ABDIG
ABJNI
ABVCZ
ACGFO
ACILI
ACXJB
ADGGA
ADHPY
AE6
AEETU
AFDTB
AGINI
AHQNM
AHRYX
AINUH
AJNWD
AJZMW
ALMTX
AMKUR
AMNEI
AOHHW
BS7
CGR
CUY
CVF
DIWNM
ECM
EEVPB
EIF
FCALG
GNXGY
GQDEL
HLJTE
HZ~
IKREB
IPNFZ
NPM
OWU
OWV
OWX
OWZ
T8P
TEORI
TSPGW
VVN
W3M
XXN
XYM
ZFV
ZZMQN
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c354b-77360541717e8dea7348edd43832c87dce8e3a8da44a3a9afe444327e0363be13
ISSN 0143-3636
IngestDate Thu Aug 15 23:16:37 EDT 2024
Fri Aug 23 02:11:33 EDT 2024
Sat Sep 28 07:46:26 EDT 2024
Thu Aug 13 19:53:28 EDT 2020
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c354b-77360541717e8dea7348edd43832c87dce8e3a8da44a3a9afe444327e0363be13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19436230
PQID 67349403
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_67349403
crossref_primary_10_1097_MNM_0b013e32832cc2ab
pubmed_primary_19436230
wolterskluwer_health_10_1097_MNM_0b013e32832cc2ab
ProviderPackageCode L-C
C45
AARTV
ADFPA
ASCII
OLG
ODA
ABZAD
ABBUW
JK3
ADNKB
JK8
H0~
OLV
8L-
JG8
OLW
OLZ
F2K
F2L
OHASI
AHVBC
AJNYG
FL-
KMI
K8S
AJIOK
OPUJH
V2I
S4R
S4S
4Q1
DUNZO
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
71W
AHULI
ACEWG
.Z2
AWKKM
OUVQU
ORVUJ
X3V
X3W
ACDDN
ACWRI
E.X
OWW
OCUKA
OWY
ACXNZ
OL1
ABXVJ
IN~
KD2
OXXIT
ACWDW
JF9
PublicationCentury 2000
PublicationDate 2009-July
2009-Jul
2009-07-00
20090701
PublicationDateYYYYMMDD 2009-07-01
PublicationDate_xml – month: 07
  year: 2009
  text: 2009-July
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Nuclear medicine communications
PublicationTitleAlternate Nucl Med Commun
PublicationYear 2009
Publisher Lippincott Williams & Wilkins, Inc
Publisher_xml – name: Lippincott Williams & Wilkins, Inc
References Decaussin (R26-13-20210212) 2002; 26
Ruegemer (R6-13-20210212) 1988; 67
Durante (R18-13-20210212) 2006; 91
Dietlein (R20-13-20210212) 2005
Massin (R23-13-20210212) 1984; 53
Sampson (R1-13-20210212) 2007; 110
Shaha (R2-13-20210212) 1997; 174
Schlumberger (R7-13-20210212) 1986; 63
Schlumberger (R22-13-20210212) 1996; 37
Sugitani (R16-13-20210212) 2008; 143
Zetting (R27-13-20210212) 2002; 56
Smith (R29-13-20210212) 1988; 62
La Quaglia (R10-13-20210212) 2000; 35
Mizukami (R28-13-20210212) 1990; 21
Muresan (R3-13-20210212) 2008; 15
Stefanovic (R17-13-20210212) 2001; 6
Lin (R19-13-20210212) 1999; 9
Nemec (R24-13-20210212) 1979; 18
Brink (R9-13-20210212) 2001; 128
Haq (R11-13-20210212) 2005; 63
Samaan (R5-13-20210212) 1983; 56
Shoup (R4-13-20210212) 2003; 197
Sobin (R13-13-20210212) 2002
Brown (R8-13-20210212) 1984; 57
Mihailovic (R15-13-20210212) 2007; 22
Brierley (R14-13-20210212) 2005; 63
Pomorski (R21-13-20210212) 1999; 46
Dinneen (R25-13-20210212) 1995; 80
References_xml – volume: 56
  start-page: 377
  year: 2002
  ident: R27-13-20210212
  article-title: Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma-surgery or conventional therapy?
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1046/j.1365-2265.2002.01482.x
  contributor:
    fullname: Zetting
– volume: 46
  start-page: 309
  year: 1999
  ident: R21-13-20210212
  article-title: Metastasis as the first sign of thyroid cancer
  publication-title: Neoplasma
  contributor:
    fullname: Pomorski
– volume: 143
  start-page: 35
  year: 2008
  ident: R16-13-20210212
  article-title: Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control
  publication-title: Surgery
  doi: 10.1016/j.surg.2007.06.011
  contributor:
    fullname: Sugitani
– volume: 63
  start-page: 418
  year: 2005
  ident: R14-13-20210212
  article-title: Prognostic factors and the effect of treatment with radioactive iodine and external radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2005.02358.x
  contributor:
    fullname: Brierley
– volume: 22
  start-page: 250
  year: 2007
  ident: R15-13-20210212
  article-title: Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors
  publication-title: Cancer Biother Radipharm
  contributor:
    fullname: Mihailovic
– volume: 53
  start-page: 982
  year: 1984
  ident: R23-13-20210212
  article-title: Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment
  publication-title: Cancer
  doi: 10.1002/1097-0142(19840215)53:4<982::AID-CNCR2820530427>3.0.CO;2-E
  contributor:
    fullname: Massin
– volume: 128
  start-page: 881
  year: 2001
  ident: R9-13-20210212
  article-title: Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis
  publication-title: Surgery
  doi: 10.1067/msy.2000.109728
  contributor:
    fullname: Brink
– volume: 21
  start-page: 283
  year: 1990
  ident: R28-13-20210212
  article-title: Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study
  publication-title: Human Pathology
  doi: 10.1016/0046-8177(90)90228-W
  contributor:
    fullname: Mizukami
– volume: 35
  start-page: 955
  year: 2000
  ident: R10-13-20210212
  article-title: Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients with distant metastases. A report from the surgical discipline committee of the children's cancer group
  publication-title: J Pediatr Surg
  doi: 10.1053/jpsu.2000.6935
  contributor:
    fullname: La Quaglia
– volume: 62
  start-page: 1381
  year: 1988
  ident: R29-13-20210212
  article-title: Mortality from papillary thyroid carcinoma. A case-control study of 56 lethal cases
  publication-title: Cancer
  doi: 10.1002/1097-0142(19881001)62:7<1381::AID-CNCR2820620724>3.0.CO;2-R
  contributor:
    fullname: Smith
– volume: 15
  start-page: 37
  year: 2008
  ident: R3-13-20210212
  article-title: Bone metastases from differentiated thyroid carcinoma
  publication-title: Endocr Relat Cancer
  doi: 10.1677/ERC-07-0229
  contributor:
    fullname: Muresan
– volume: 63
  start-page: 87
  year: 2005
  ident: R11-13-20210212
  article-title: Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome
  publication-title: Clin Endocrinol
  doi: 10.1111/j.1365-2265.2005.02304.x
  contributor:
    fullname: Haq
– volume: 9
  start-page: 1227
  year: 1999
  ident: R19-13-20210212
  article-title: Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases
  publication-title: Thyroid
  doi: 10.1089/thy.1999.9.1227
  contributor:
    fullname: Lin
– volume: 80
  start-page: 2041
  year: 1995
  ident: R25-13-20210212
  article-title: Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Dinneen
– volume: 197
  start-page: 191
  year: 2003
  ident: R4-13-20210212
  article-title: Prognostic Indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma
  publication-title: J Am Coll Surg
  doi: 10.1016/S1072-7515(03)00332-6
  contributor:
    fullname: Shoup
– volume: 6
  start-page: 263
  year: 2001
  ident: R17-13-20210212
  article-title: Treatment outcome in patients with differentiated thyroid carcinoma and distant metastases
  publication-title: J BUON
  contributor:
    fullname: Stefanovic
– volume: 63
  start-page: 960
  year: 1986
  ident: R7-13-20210212
  article-title: Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-63-4-960
  contributor:
    fullname: Schlumberger
– volume: 91
  start-page: 2892
  year: 2006
  ident: R18-13-20210212
  article-title: Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-2838
  contributor:
    fullname: Durante
– year: 2002
  ident: R13-13-20210212
  article-title: TNM classification of malignant tumours. 6th ed
  contributor:
    fullname: Sobin
– volume: 18
  start-page: 86
  year: 1979
  ident: R24-13-20210212
  article-title: Radioiodine treatment of pulmonary metastases of differentiated thyroid cancer. Results and prognostic factors
  publication-title: Nuklearmedizin
  doi: 10.1055/s-0037-1620881
  contributor:
    fullname: Nemec
– start-page: 95
  year: 2005
  ident: R20-13-20210212
  article-title: Thyroid cancer. 2nd ed
  contributor:
    fullname: Dietlein
– volume: 110
  start-page: 1451
  year: 2007
  ident: R1-13-20210212
  article-title: 2007 Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metasasis at diagnosis
  publication-title: Cancer
  doi: 10.1002/cncr.22956
  contributor:
    fullname: Sampson
– volume: 56
  start-page: 1131
  year: 1983
  ident: R5-13-20210212
  article-title: Impact of therapy for differentiated carcinoma of the thyroid: analysis of 706 cases
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-56-6-1131
  contributor:
    fullname: Samaan
– volume: 26
  start-page: 1007
  year: 2002
  ident: R26-13-20210212
  article-title: Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular component
  publication-title: Am J Surg Pathol
  doi: 10.1097/00000478-200208000-00005
  contributor:
    fullname: Decaussin
– volume: 57
  start-page: 323
  year: 1984
  ident: R8-13-20210212
  article-title: Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience
  publication-title: Br J Radiol
  doi: 10.1259/0007-1285-57-676-323
  contributor:
    fullname: Brown
– volume: 174
  start-page: 474
  year: 1997
  ident: R2-13-20210212
  article-title: Differentiated thyroid cancer presenting initially with distant metasrtasis
  publication-title: Am J Surg
  doi: 10.1016/S0002-9610(97)00158-X
  contributor:
    fullname: Shaha
– volume: 67
  start-page: 501
  year: 1988
  ident: R6-13-20210212
  article-title: Distant metasatsis in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-67-3-501
  contributor:
    fullname: Ruegemer
– volume: 37
  start-page: 598
  year: 1996
  ident: R22-13-20210212
  article-title: Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma
  publication-title: J Nucl Med
  contributor:
    fullname: Schlumberger
SSID ssj0008367
Score 1.9877352
Snippet OBJECTIVEOur objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant...
Our objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant metastases...
SourceID proquest
crossref
pubmed
wolterskluwer
SourceType Aggregation Database
Index Database
Publisher
StartPage 558
SubjectTerms Age Factors
Female
Humans
Iodine Radioisotopes - therapeutic use
Male
Middle Aged
Neoplasm Metastasis
Retrospective Studies
Survival Rate
Thyroid Neoplasms - pathology
Thyroid Neoplasms - radiotherapy
Thyroid Neoplasms - therapy
Time Factors
Treatment Outcome
Title Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases
URI https://www.ncbi.nlm.nih.gov/pubmed/19436230
https://search.proquest.com/docview/67349403
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZpC2NjjN2bXfWwt2EWW3Jk7610KS3E2cNS6JuRZYW5beySxOxP7EfvHEuyknXs8rAXExQhG3-fzznSuRHyTidgdicg_RbRWAVcxyxIkzgKQrbQXIXFSHQZcqdfxOwi-TThk8HAdWb0Y_8VaRgDrDFz9h_Q7heFAfgNmMMVUIfrX-Ge6Y3ELKFK9c1P4CNGuxIgWTVVicWoVVU3y64rT58ZuezjYDp_QtNu4Om6AwXrw3nvq7DalLgKA49srYFruAXOxKbE2JYan2Ft4xMvXYqvwh4VvTsfw9l9ckpv22fVV1ldNyDBTBTvupbbTY_1Qtbuz-llWzTLauV9WxnoO9T1yqQE4Imkj2merOSVy09q7LA78Ej74FjQV0ZIc8ECsNuSbSluvTuGrWJLJMemNLzV7rGpmX5LcZiCxNkscyfD2MJJqUgWXlG64IDZ5_zkfDrN55OL-R45iEDEgYQ9ODo-m571VkDCxsKlaqbiw69W3jWFbu1v7pH73xoMmVhfdRkTW3bP_CF5YDcs9Mgw7REZ6PoxuZNZDJ-Q755wdJdw1BKO9oT7SB3dqKcbBfpQSzfaLKilG61q6uhGkW7U0q2bj3Sjlm7U0-0pOT-ZzI9PA9viI1As5gXs7Rjsp3koQqGTUkustaTLEuvnRioRpdKJZjIpJeeSyVSCAOGcRUJj_EGhQ_aM7NdNrQ8JleNoFI-KMowUg0m8KJQOUz7iukiVFNGQBO5t5zemkkvuIjAAnfxndIbkrYMkB5GLfjRZ66ZdYygkh4XZkDw3SPn1Ug4GIRsNSbgDXW6Smn97vxd_vN9Lctd_D6_I_mbV6tdkb122byz7fgDqqMIE
link.rule.ids 315,782,786,27933,27934
linkProvider Ovid
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metastatic+differentiated+thyroid+carcinoma%3A+clinical+management+and+outcome+of+disease+in+patients+with+initial+and+late+distant+metastases&rft.jtitle=Nuclear+medicine+communications&rft.au=Mihailovic%2C+Jasna+M&rft.au=Stefanovic%2C+Ljubomir+J&rft.au=Malesevic%2C+Milica+D&rft.au=Erak%2C+Marko+D&rft.date=2009-07-01&rft.eissn=1473-5628&rft.volume=30&rft.issue=7&rft.spage=558&rft.epage=564&rft_id=info:doi/10.1097%2FMNM.0b013e32832cc2ab&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-3636&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-3636&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-3636&client=summon